Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease

Archives of Internal Medicine

Volumn 158, Issue 19, 1998, Pages 2101-2106

  Ray, Joel G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; THROMBOEMBOLISM;

EID: 0032569645     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.19.2101     Document Type: Article

References (31)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
2. Spector TD, Thompson SG. The potential and limitations of meta-analyses. J Epidemiol Community Health. 1991;45:89-92.
3. Brosnan JT, Hall B, Selhub J, Nadeau MR, Bostom AG. Renal metabolism of homocysteine in vivo [abstract]. Biochem Soc Trans. 1995;23:470S.
4. Janssen MJ, van den Berg M, Stehouwer CD, Boers GH. Hyperhomocysteinemia: a role in the accelerated atherogenesis of chronic renal failure? Neth J Med. 1995;46:244-251.
5. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47-53.
6. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92:2825-2830.
7. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88: 1463-1469.
8. Berg K, Malinow MR, Kierulf P, Upson B. Population variation and genetics of plasma homocyst(e)ine level. Clin Genet. 1992;41:315-321.
9. Shapiro S. Meta-analysis/shmeta-analysis. Am J Epidemiol. 1994;140:771-778.
10. Petitti DB. Of babies and bathwater. Am J Epidemiol. 1994;140:779-782.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188.
12. Breslow NE, Day NE. Statistical methods in cancer research, vol 1: the analysis of case-control studies. IARC Sci Publ. 1980;32:5-338.
13. Brattstrom L, Tengborn L, Lagerstedt C, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism. Haemostasis. 1991;21:51-57.
14. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis: relation to coagulation and fibrinolytic parameters. Thromb Res. 1993;70:123-129.
15. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-1083.
16. den Heijer M, Blom HJ, Gerrits WB, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-885.
17. Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vasc Biol. 1995;15:1321-1323.
18. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.
19. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [letter] [published correction appears in N Engl J Med. 1997;336:1399]. N Engl J Med. 1996;335:974-975.
20. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [letter] [published correction appears in N Engl J Med. 1997;336:1399]. N Engl J Med. 1996;335:974-975.
21. Simioni P, Prandoni P, Burlina A, et al. Hyperhomocysteinemia and deep-vein thrombosis: a case-control study. Thromb Haemost. 1996;76:883-886.
22. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997;95:1777-1782.
23. Fermo I, Vigano' D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med. 1995;123:747-753.
24. Petitti DB. Meta-analysis, Decision Analysis, and Cost-effective Analysis: Methods for Quantitative Synthesis in Medicine. New York, NY: Oxford University Press; 1994:90-130, 228.
25. Fermo I, Arcelloni C, De Vecchi E, Vigano S, Paroni R. High-performance liquid chromatographic method with fluorescence detection for the determination of total homocyst(e)ine in plasma. J Chromatogr. 1992;593:171-176.
26. Fortin LJ, Genest J Jr. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem. 1995;28:155-162.
27. den Heijer M, Blom HJ, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [letter]. N Engl J Med. 1996;335:975-976.
28. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in antithrombin-III-deficient persons: report of a large kindred and literature review. Ann Intern Med. 1992;116:754-761.
29. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989; 73:712-717.
30. Franken DG, Boers GHJ, Blom HJ, Tijbels FJM, Kloppenborg PW. Treatment of mild hyperhomocysteinemia in vascular patients. Arterioscler Thromb. 1994;14: 465-470.
31. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994;124:1927-1933.